ArticleCureus2025
A Curious Presentation of a Human Papillomavirus (HPV)-Driven Pelvic Squamous Cell Carcinoma of Unknown Primary: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Squamous cell carcinoma of unknown primary in the pelvis after complete remission following chemoradiotherapy: A case report.World journal of clinical cases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancers of unknown primary (CUP) are rare malignancies among invasive cancers and are comprised of a variety of subtypes. In the pelvis, occult squamous cell carcinoma (SCC) usually arises from the vulva, vagina, cervix, or anus. We present the case of a 55-year-old patient with pelvic pain. Magnetic resonance imaging showed a presacral and posterior lower uterine soft tissue mass measuring 6.7 x 5.0 x 6.2 cm with regional lymph node involvement. An exam under anesthesia and colonoscopy did not detect cervical or anal involvement. A biopsy of the mass confirmed poorly differentiated SCC, positive p16 staining on immunohistochemistry, and human papillomavirus (HPV+) RNA in-situ hybridization. The findings were most consistent with an atypical presentation of locally advanced cervical cancer. The patient received chemoradiation with volumetric modulated arc therapy. After four weeks of treatment with some tumor response, she received stereotactic body radiotherapy (SBRT) as the mass was not accessible for brachytherapy. The patient ultimately had a partial response with the shrinking tumor separating from the cervix. She was re-evaluated by a multidisciplinary team, and based on response and imaging, the tumor was most likely determined to originate from the anus. Colorectal surgery assumed care for definitive abdominal perineal resection. This case demonstrates the importance of continuous evaluation of the site of disease in patients with CUP and the avoidance of anchoring on a definitive diagnosis. Identification of the primary site may be impossible initially, but willingness to alter treatment as new information presents is essential to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.